Cargando…
Phenolic Esters of O-Desmethylvenlafaxine with Improved Oral Bioavailability and Brain Uptake
O-Desmethylvenlafaxine (desvenlafaxine, ODV) is a recently approved antidepressant which in some clinical studies failed to meet a satisfactory end-point. The aim of this study was to prepare a series of phenolic esters of ODV and evaluate their potential as ODV prodrugs with improved brain uptake....
Autores principales: | Zhang, Yang, Yang, Yan, Zhao, Sen, Yang, Zhichao, Yang, Hong, Fawcett, J. Paul, Li, Youxin, Gu, Jingkai, Sun, Tiemin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270635/ https://www.ncbi.nlm.nih.gov/pubmed/24304586 http://dx.doi.org/10.3390/molecules181214920 |
Ejemplares similares
-
Advances in Research at Synthesis Process Optimization and Quality Standard Improvement of O-desmethylvenlafaxine Succinate
por: Yang, Shiwei, et al.
Publicado: (2022) -
Determination of venlafaxine and its active metabolite O-desmethylvenlafaxine in human plasma by HPLC fluorescence
por: Shen, Shujuan, et al.
Publicado: (2018) -
Pharmacokinetics of venlafaxine and its major metabolite o-desmethylvenlafaxine in freely moving mice using automated dosing/sampling system
por: Aryal, Bijay, et al.
Publicado: (2012) -
Measurement of Hepatic CYP3A4 and 2D6 Activity Using Radioiodine-Labeled O-Desmethylvenlafaxine
por: Mizutani, Asuka, et al.
Publicado: (2022) -
Impact of molecular weight on the mechanism of cellular uptake of polyethylene glycols (PEGs) with particular reference to P-glycoprotein
por: Wang, Tingting, et al.
Publicado: (2020)